Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04804124 · ClinicalTrials.gov registry record · NA

Sleep Duration and Cardiovascular Health

A NA study of Sleep and Cardiovascular Risk Factor, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04804124 is a NA study of Sleep and Cardiovascular Risk Factor that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 24 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04804124, a NA study of Sleep and Cardiovascular Risk Factor, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This is a cross-sectional study with an optional intervention that will examine how extreme sleep durations relate to cardiovascular health, physical activity, and sleep quality by studying three groups of participants: short sleepers (≤ 6 hrs), long sleepers (≥ 9 hrs), and average duration sleepers (7-8 hrs). The optional intervention asks participants to maintain an 8-hour per night regular sleep schedule for one week.

Interventions

  • BEHAVIORAL Regularized Sleep Schedule

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-06-09
Est. Completion 2026-03-15
Phase NA

What the Registry Record Tells You About NCT04804124

The ClinicalTrials.gov registry entry for NCT04804124 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (99% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Regularized Sleep Schedule is the first listed.

NCT04804124 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT04804124 about?

NCT04804124 is a clinical study titled "Sleep Duration and Cardiovascular Health". This is a cross-sectional study with an optional intervention that will examine how extreme sleep durations relate to cardiovascular health, physical activity, and sleep quality by studying three groups of participants: short sleepers (≤ 6 hrs), long sleepers (≥ 9 hrs), and average duration sleepers...

What is the current status of trial NCT04804124?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2021-06-09. Estimated completion is 2026-03-15.

What conditions does trial NCT04804124 study?

This clinical trial studies the following conditions: Sleep, Cardiovascular Risk Factor.

What interventions are being tested in trial NCT04804124?

The interventions under investigation include: Regularized Sleep Schedule (BEHAVIORAL).

Who is sponsoring clinical trial NCT04804124?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04804124 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.